サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1172684

心臓マーカー検査の世界市場規模、シェア、産業動向分析レポート：疾患別、エンドユーザー別、製品別（試薬・キット、機器）、バイオマーカータイプ別、地域別展望・予測、2022年～2028年

Global Cardiac Marker Testing Market Size, Share & Industry Trends Analysis Report By Disease, By End User, By Product (Reagents & Kits and Instruments), By Biomarker Type, By Regional Outlook and Forecast, 2022 - 2028
出版日: | 発行: KBV Research | ページ情報: 英文 303 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
心臓マーカー検査の世界市場規模、シェア、産業動向分析レポート：疾患別、エンドユーザー別、製品別（試薬・キット、機器）、バイオマーカータイプ別、地域別展望・予測、2022年～2028年
出版日: 2022年11月30日
発行: KBV Research
ページ情報: 英文 303 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心臓マーカー検査の世界市場規模は、予測期間中にCAGR8.3％で成長し、2028年には81億米ドルに達すると予測されます。

動脈壁におけるプラークの形成と動脈硬化は、一般的にACSと心筋虚血の両方の主な原因となっています。このため、冠動脈の血流が突然遮断されたり、心臓につながる動脈が著しく収縮したりすることがあります。

トロポニンは、心臓の損傷を特定するためのバイオマーカー検査として、現在、好んで使用されています。骨格筋損傷などの他の状況では、追加の心臓バイオマーカーが上昇することがあるが、心臓に対する特異性は低いです。急性冠症候群（ACS）、急性心不全、肺塞栓症、その他の疾患状態が疑われる患者の診断、リスク評価、治療、およびこれらの疾患を持つ患者の予後は、すべて心臓の徴候に依存しています。

COVID-19インパクト分析

心臓マーカー検査市場は、COVID-19のパンデミックの影響から引き続き恩恵を受けると予想されます。これは、心血管疾患などの既往症を持つCOVID-19患者が増加するためです。このような心血管系疾患などの持病を持つ患者さんでは心臓発作が多いので、亡くなった方や危篤状態のCOVID-19患者さんではトロポニン値も有意に高くなると考えられました。COVID-19の患者さんにとっては、心臓のバイオマーカー検査の需要が高まっているのです。したがって、これらの変数をすべて考慮すると、心臓マーカー検査の市場は、この大流行を通じて大きな成長を示し、さらに増加すると予想されます。

市場成長要因

心血管疾患の有病率の上昇

世界中で人々のライフスタイルが急速に変化するにつれ、数多くの疾患や障害が増加しています。ライフスタイルの変化は、心血管疾患を含む大きな健康問題につながる可能性があります。不健康な食事、運動不足、タバコの使用、過度のアルコール摂取は、心血管疾患および脳卒中の修正可能な主要な危険因子です。高血圧、脂質異常、糖尿病、肥満などの症状は、すべてライフスタイルの選択に起因しています。

ヘルスケア支出の増加

心臓マーカー検査へのアクセスを増加させる主な要因の1つは、世界中の様々な国のヘルスケアシステムの発展です。がんやその他の疾患の増加の結果、世界中の政府がヘルスケアシステムに多くの時間と資金を投入しています。さらに、現在進行中のパンデミックによって、ヘルスケア産業は新たな課題への適応を迫られており、世界中のヘルスケアシステムの注意とリソースが引き続き必要とされています。

市場の抑制要因

サンプルの保管・採取に関する技術的な問題

ヒトの疾病が進行する様々な段階に関する研究を行うため、疫学研究では心臓バイオマーカーが利用されています。この方法では、少数の生体試料から多くの知見を得るために、試料の慎重な処理と長期保存が必要です。そのため、適切な保存条件を確保し、データの損失を防ぐために、サンプルの徹底した品質チェックが必要です。

製品の展望

心臓セグメンテーション市場は、製品によって試薬・キットと機器に区分されます。2021年の心臓マーカー検査市場では、器具部門がかなりの収益シェアを獲得しています。ACSだけでなく、心臓虚血の発生を特定し、その重症度を評価するために、心臓バイオマーカー検査が処方されます。ACSまたは心臓虚血の患者は、血液中の1つまたはそれ以上の心臓マーカーの上昇によって特定することができ、迅速かつ正確な診断と正しい治療方針が可能になります。

バイオマーカータイプの展望

心臓マーカー検査市場は、バイオマーカーの種類によって、トロポニンI・T、クレアチンキナーゼMB（CK-MB）、ナトリウム利尿ペプチド（BnpまたはNt-Probnp）、ミオグロビン、高感度CRP（hs-CRP）、その他の心臓マーカーに分類されます。2021年、トロポニンI＆Tセグメントは心臓マーカー検査市場で最大の収益シェアを占めました。より優れた感度と特異性により、心臓トロポニンは急性心筋梗塞の診断に再び好ましいバイオマーカーとなっています。最近では、高感度トロポニン検査が数多く市場に投入されています。

疾患別展望

心臓マーカー検査市場は、疾患別に心筋梗塞、うっ血性心不全、急性冠症候群、動脈硬化症、虚血に分けられます。2021年、心臓マーカー検査市場では、急性冠症候群のセグメントがかなりの収益シェアを記録しました。これは、高所得国に比べて貧困国や中所得国での疾病負担が急速に増加しているためです。

エンドユーザー展望

エンドユーザーに基づいて、心臓マーカー検査市場は、ラボラトリー検査施設、Point of Care検査施設、学術機関に分類されます。2021年、心臓マーカー検査市場では、ラボラトリー検査部門が最大の収益シェアを獲得しました。この成長の背景には、ヘルスケアインフラの改革、医療費の増加、支出力の上昇、心臓発作予防のための取り組みなどの要因があります。

地域別展望

地域別に見ると、心臓マーカー検査市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。2021年には、北米地域が最も高い収益シェアで心臓マーカー検査市場をリードしました。この要因としては、研究開発への実質的な投資、主要プレイヤーの存在、自社製品へのアクセスのしやすさ、などが挙げられます。

市場参入企業がとっている主な戦略は、製品の上市です。Cardinalマトリックスで提示された分析によると、F. Hoffmann-La Roche Ltd.が心臓マーカー検査市場における主要な先駆者です。Abbott Laboratories、Thermo Fisher Scientific, Inc.、Danaher Corporationなどの企業は、Cardiac Marker Testing市場における主要な革新者の一人です。

目次

第1章 市場の範囲と調査手法

  • 市場の定義
  • 目的
  • 市場規模
  • セグメンテーション
    • 心臓マーカー検査の世界市場、疾患別
    • 心臓マーカー検査の世界市場、エンドユーザー別
    • 心臓マーカー検査の世界市場、製品別
    • 心臓マーカー検査の世界市場、バイオマーカータイプ別
    • 心臓マーカー検査の世界市場、地域別
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要説明
      • 市場の構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場の抑制要因

第3章 競合分析-世界

  • KBVカーディナルマトリックス
  • 最近の業界全体の戦略的展開
    • パートナーシップ、コラボレーション、契約
    • 製品上市と製品拡張
    • 買収と合併
    • トレイルと承認
  • 主要成功戦略
    • 主要なリーディング戦略：割合の分布（2018年～2022年）

第4章 心臓マーカー検査の世界市場：疾患別

  • 心筋梗塞の世界市場：地域別
  • うっ血性心不全の世界市場：地域別
  • 動脈硬化の世界市場：地域別
  • 急性冠症候群の世界市場：地域別
  • 虚血の世界市場：地域別

第5章 心臓マーカー検査の世界市場：エンドユーザー別

  • ラボラトリー検査施設の世界市場：地域別
  • Point-of-Care Testing Facilitiesの世界市場：地域別
  • 学術機関の世界市場：地域別

第6章 心臓マーカー検査の世界市場：製品別

  • 試薬・キットの世界市場：地域別
  • 機器の世界市場：地域別

第7章 心臓マーカー検査の世界市場：バイオマーカータイプ別

  • トロポニンi・Tの世界市場：地域別
  • クレアチンキナーゼ-MB（CK-MB）の世界地域別市場
  • ナトリウム利尿ペプチド（Bnp Or Nt-Probnp）の世界市場：地域別
  • ミオグロビンの世界市場：地域別
  • 高感度CRP（hs-CRP）の世界市場：地域別
  • 世界の地域別その他市場

第8章 心臓マーカー検査の世界市場。地域別市場

  • 北米
    • 北米の心臓マーカー検査の国別市場
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の心臓マーカー検査市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域の心臓マーカー検査市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • LAMEA
    • LAMEAの心臓マーカー検査市場：国別
      • ブラジル
      • アルゼンチン
      • UAE
      • サウジアラビア
      • 南アフリカ共和国
      • ナイジェリア
      • LAMEAの残りの地域

第9章 企業プロファイル

  • Abbott Laboratories
  • Siemens Healthineers AG（Siemens AG）
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad laboratories, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A
  • PerkinElmer, Inc.
  • BioMerieux S.A
図表

LIST OF TABLES

  • TABLE 1 Global Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 2 Global Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Cardiac Marker Testing Market
  • TABLE 4 Product Launches And Product Expansions- Cardiac Marker Testing Market
  • TABLE 5 Acquisition and Mergers- Cardiac Marker Testing Market
  • TABLE 6 Acquisition and Mergers- Cardiac Marker Testing Market
  • TABLE 7 Global Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 8 Global Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 9 Global Myocardial Infarction Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Myocardial Infarction Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Congestive Heart Failure Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Congestive Heart Failure Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Atherosclerosis Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Atherosclerosis Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Acute Coronary Syndrome Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Acute Coronary Syndrome Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Ischemia Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Ischemia Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 20 Global Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 21 Global Laboratory Testing Facilities Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Laboratory Testing Facilities Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Point-of-Care Testing Facilities Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Point-of-Care Testing Facilities Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Academic Institutions Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Academic Institutions Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 28 Global Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 29 Global Reagents & Kits Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Reagents & Kits Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Instruments Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 33 Global Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 34 Global Troponin I & T Market by Region, 2018 - 2021, USD Million
  • TABLE 35 Global Troponin I & T Market by Region, 2022 - 2028, USD Million
  • TABLE 36 Global Creatine kinase-MB(CK-MB) Market by Region, 2018 - 2021, USD Million
  • TABLE 37 Global Creatine kinase-MB(CK-MB) Market by Region, 2022 - 2028, USD Million
  • TABLE 38 Global Natriuretic peptide (Bnp Or Nt-Probnp) Market by Region, 2018 - 2021, USD Million
  • TABLE 39 Global Natriuretic peptide (Bnp Or Nt-Probnp) Market by Region, 2022 - 2028, USD Million
  • TABLE 40 Global Myoglobin Market by Region, 2018 - 2021, USD Million
  • TABLE 41 Global Myoglobin Market by Region, 2022 - 2028, USD Million
  • TABLE 42 Global High-sensitivity C-reactive protein(hs-CRP) Market by Region, 2018 - 2021, USD Million
  • TABLE 43 Global High-sensitivity C-reactive protein(hs-CRP) Market by Region, 2022 - 2028, USD Million
  • TABLE 44 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 45 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 46 Global Cardiac Marker Testing Market by Region, 2018 - 2021, USD Million
  • TABLE 47 Global Cardiac Marker Testing Market by Region, 2022 - 2028, USD Million
  • TABLE 48 North America Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 49 North America Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 50 North America Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 51 North America Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 52 North America Myocardial Infarction Market by Country, 2018 - 2021, USD Million
  • TABLE 53 North America Myocardial Infarction Market by Country, 2022 - 2028, USD Million
  • TABLE 54 North America Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
  • TABLE 55 North America Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
  • TABLE 56 North America Atherosclerosis Market by Country, 2018 - 2021, USD Million
  • TABLE 57 North America Atherosclerosis Market by Country, 2022 - 2028, USD Million
  • TABLE 58 North America Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 59 North America Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 60 North America Ischemia Market by Country, 2018 - 2021, USD Million
  • TABLE 61 North America Ischemia Market by Country, 2022 - 2028, USD Million
  • TABLE 62 North America Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 63 North America Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 64 North America Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
  • TABLE 65 North America Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
  • TABLE 66 North America Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
  • TABLE 67 North America Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
  • TABLE 68 North America Academic Institutions Market by Country, 2018 - 2021, USD Million
  • TABLE 69 North America Academic Institutions Market by Country, 2022 - 2028, USD Million
  • TABLE 70 North America Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 71 North America Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 72 North America Reagents & Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 73 North America Reagents & Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 74 North America Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 75 North America Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 76 North America Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 77 North America Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 78 North America Troponin I & T Market by Country, 2018 - 2021, USD Million
  • TABLE 79 North America Troponin I & T Market by Country, 2022 - 2028, USD Million
  • TABLE 80 North America Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
  • TABLE 81 North America Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
  • TABLE 82 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
  • TABLE 83 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
  • TABLE 84 North America Myoglobin Market by Country, 2018 - 2021, USD Million
  • TABLE 85 North America Myoglobin Market by Country, 2022 - 2028, USD Million
  • TABLE 86 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
  • TABLE 87 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
  • TABLE 88 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 89 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 90 North America Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 91 North America Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 92 US Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 93 US Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 94 US Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 95 US Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 96 US Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 97 US Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 98 US Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 99 US Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 100 US Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 101 US Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 102 Canada Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 103 Canada Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 104 Canada Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 105 Canada Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 106 Canada Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 107 Canada Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 108 Canada Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 109 Canada Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 110 Canada Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 111 Canada Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 112 Mexico Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 113 Mexico Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 114 Mexico Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 115 Mexico Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 116 Mexico Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 117 Mexico Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 118 Mexico Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 119 Mexico Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 120 Mexico Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 121 Mexico Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 122 Rest of North America Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 123 Rest of North America Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 124 Rest of North America Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 125 Rest of North America Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 126 Rest of North America Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 127 Rest of North America Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 128 Rest of North America Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 129 Rest of North America Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 130 Rest of North America Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 131 Rest of North America Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 132 Europe Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 133 Europe Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 134 Europe Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 135 Europe Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 136 Europe Myocardial Infarction Market by Country, 2018 - 2021, USD Million
  • TABLE 137 Europe Myocardial Infarction Market by Country, 2022 - 2028, USD Million
  • TABLE 138 Europe Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
  • TABLE 139 Europe Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
  • TABLE 140 Europe Atherosclerosis Market by Country, 2018 - 2021, USD Million
  • TABLE 141 Europe Atherosclerosis Market by Country, 2022 - 2028, USD Million
  • TABLE 142 Europe Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 143 Europe Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 144 Europe Ischemia Market by Country, 2018 - 2021, USD Million
  • TABLE 145 Europe Ischemia Market by Country, 2022 - 2028, USD Million
  • TABLE 146 Europe Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 147 Europe Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 148 Europe Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
  • TABLE 149 Europe Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
  • TABLE 150 Europe Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
  • TABLE 151 Europe Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
  • TABLE 152 Europe Academic Institutions Market by Country, 2018 - 2021, USD Million
  • TABLE 153 Europe Academic Institutions Market by Country, 2022 - 2028, USD Million
  • TABLE 154 Europe Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 155 Europe Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 156 Europe Reagents & Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 157 Europe Reagents & Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 158 Europe Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 159 Europe Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 160 Europe Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 161 Europe Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 162 Europe Troponin I & T Market by Country, 2018 - 2021, USD Million
  • TABLE 163 Europe Troponin I & T Market by Country, 2022 - 2028, USD Million
  • TABLE 164 Europe Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
  • TABLE 165 Europe Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
  • TABLE 166 Europe Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
  • TABLE 167 Europe Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
  • TABLE 168 Europe Myoglobin Market by Country, 2018 - 2021, USD Million
  • TABLE 169 Europe Myoglobin Market by Country, 2022 - 2028, USD Million
  • TABLE 170 Europe High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
  • TABLE 171 Europe High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
  • TABLE 172 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 173 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 174 Europe Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 175 Europe Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 176 Germany Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 177 Germany Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 178 Germany Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 179 Germany Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 180 Germany Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 181 Germany Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 182 Germany Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 183 Germany Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 184 Germany Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 185 Germany Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 186 UK Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 187 UK Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 188 UK Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 189 UK Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 190 UK Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 191 UK Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 192 UK Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 193 UK Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 194 UK Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 195 UK Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 196 France Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 197 France Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 198 France Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 199 France Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 200 France Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 201 France Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 202 France Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 203 France Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 204 France Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 205 France Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 206 Russia Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 207 Russia Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 208 Russia Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 209 Russia Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 210 Russia Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 211 Russia Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 212 Russia Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 213 Russia Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 214 Russia Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 215 Russia Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 216 Spain Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 217 Spain Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 218 Spain Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 219 Spain Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 220 Spain Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 221 Spain Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 222 Spain Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 223 Spain Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 224 Spain Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 225 Spain Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 226 Italy Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 227 Italy Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 228 Italy Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 229 Italy Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 230 Italy Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 231 Italy Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 232 Italy Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 233 Italy Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 234 Italy Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 235 Italy Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 236 Rest of Europe Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 237 Rest of Europe Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 238 Rest of Europe Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 239 Rest of Europe Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 240 Rest of Europe Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 241 Rest of Europe Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 242 Rest of Europe Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 243 Rest of Europe Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 244 Rest of Europe Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 245 Rest of Europe Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 246 Asia Pacific Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 247 Asia Pacific Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 248 Asia Pacific Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 249 Asia Pacific Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 250 Asia Pacific Myocardial Infarction Market by Country, 2018 - 2021, USD Million
  • TABLE 251 Asia Pacific Myocardial Infarction Market by Country, 2022 - 2028, USD Million
  • TABLE 252 Asia Pacific Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
  • TABLE 253 Asia Pacific Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
  • TABLE 254 Asia Pacific Atherosclerosis Market by Country, 2018 - 2021, USD Million
  • TABLE 255 Asia Pacific Atherosclerosis Market by Country, 2022 - 2028, USD Million
  • TABLE 256 Asia Pacific Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 257 Asia Pacific Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 258 Asia Pacific Ischemia Market by Country, 2018 - 2021, USD Million
  • TABLE 259 Asia Pacific Ischemia Market by Country, 2022 - 2028, USD Million
  • TABLE 260 Asia Pacific Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 261 Asia Pacific Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 262 Asia Pacific Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
  • TABLE 263 Asia Pacific Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
  • TABLE 264 Asia Pacific Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
  • TABLE 265 Asia Pacific Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
  • TABLE 266 Asia Pacific Academic Institutions Market by Country, 2018 - 2021, USD Million
  • TABLE 267 Asia Pacific Academic Institutions Market by Country, 2022 - 2028, USD Million
  • TABLE 268 Asia Pacific Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 269 Asia Pacific Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 270 Asia Pacific Reagents & Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 271 Asia Pacific Reagents & Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 272 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 273 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 274 Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 275 Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 276 Asia Pacific Troponin I & T Market by Country, 2018 - 2021, USD Million
  • TABLE 277 Asia Pacific Troponin I & T Market by Country, 2022 - 2028, USD Million
  • TABLE 278 Asia Pacific Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
  • TABLE 279 Asia Pacific Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
  • TABLE 280 Asia Pacific Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
  • TABLE 281 Asia Pacific Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
  • TABLE 282 Asia Pacific Myoglobin Market by Country, 2018 - 2021, USD Million
  • TABLE 283 Asia Pacific Myoglobin Market by Country, 2022 - 2028, USD Million
  • TABLE 284 Asia Pacific High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
  • TABLE 285 Asia Pacific High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
  • TABLE 286 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 287 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 288 Asia Pacific Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 289 Asia Pacific Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 290 China Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 291 China Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 292 China Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 293 China Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 294 China Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 295 China Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 296 China Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 297 China Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 298 China Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 299 China Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 300 Japan Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 301 Japan Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 302 Japan Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 303 Japan Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 304 Japan Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 305 Japan Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 306 Japan Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 307 Japan Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 308 Japan Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 309 Japan Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 310 India Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 311 India Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 312 India Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 313 India Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 314 India Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 315 India Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 316 India Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 317 India Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 318 India Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 319 India Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 320 South Korea Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 321 South Korea Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 322 South Korea Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 323 South Korea Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 324 South Korea Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 325 South Korea Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 326 South Korea Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 327 South Korea Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 328 South Korea Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 329 South Korea Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 330 Singapore Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 331 Singapore Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 332 Singapore Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 333 Singapore Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 334 Singapore Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 335 Singapore Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 336 Singapore Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 337 Singapore Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 338 Singapore Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 339 Singapore Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 340 Malaysia Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 341 Malaysia Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 342 Malaysia Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 343 Malaysia Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 344 Malaysia Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 345 Malaysia Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 346 Malaysia Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 347 Malaysia Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 348 Malaysia Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 349 Malaysia Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 350 Rest of Asia Pacific Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 351 Rest of Asia Pacific Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 352 Rest of Asia Pacific Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 353 Rest of Asia Pacific Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 354 Rest of Asia Pacific Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 355 Rest of Asia Pacific Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 356 Rest of Asia Pacific Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 357 Rest of Asia Pacific Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 358 Rest of Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 359 Rest of Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 360 LAMEA Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 361 LAMEA Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 362 LAMEA Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 363 LAMEA Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 364 LAMEA Myocardial Infarction Market by Country, 2018 - 2021, USD Million
  • TABLE 365 LAMEA Myocardial Infarction Market by Country, 2022 - 2028, USD Million
  • TABLE 366 LAMEA Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
  • TABLE 367 LAMEA Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
  • TABLE 368 LAMEA Atherosclerosis Market by Country, 2018 - 2021, USD Million
  • TABLE 369 LAMEA Atherosclerosis Market by Country, 2022 - 2028, USD Million
  • TABLE 370 LAMEA Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 371 LAMEA Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 372 LAMEA Ischemia Market by Country, 2018 - 2021, USD Million
  • TABLE 373 LAMEA Ischemia Market by Country, 2022 - 2028, USD Million
  • TABLE 374 LAMEA Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 375 LAMEA Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 376 LAMEA Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
  • TABLE 377 LAMEA Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
  • TABLE 378 LAMEA Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
  • TABLE 379 LAMEA Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
  • TABLE 380 LAMEA Academic Institutions Market by Country, 2018 - 2021, USD Million
  • TABLE 381 LAMEA Academic Institutions Market by Country, 2022 - 2028, USD Million
  • TABLE 382 LAMEA Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 383 LAMEA Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 384 LAMEA Reagents & Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 385 LAMEA Reagents & Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 386 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 387 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 388 LAMEA Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 389 LAMEA Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 390 LAMEA Troponin I & T Market by Country, 2018 - 2021, USD Million
  • TABLE 391 LAMEA Troponin I & T Market by Country, 2022 - 2028, USD Million
  • TABLE 392 LAMEA Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
  • TABLE 393 LAMEA Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
  • TABLE 394 LAMEA Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
  • TABLE 395 LAMEA Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
  • TABLE 396 LAMEA Myoglobin Market by Country, 2018 - 2021, USD Million
  • TABLE 397 LAMEA Myoglobin Market by Country, 2022 - 2028, USD Million
  • TABLE 398 LAMEA High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
  • TABLE 399 LAMEA High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
  • TABLE 400 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 401 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 402 LAMEA Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 403 LAMEA Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 404 Brazil Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 405 Brazil Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 406 Brazil Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 407 Brazil Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 408 Brazil Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 409 Brazil Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 410 Brazil Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 411 Brazil Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 412 Brazil Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 413 Brazil Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 414 Argentina Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 415 Argentina Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 416 Argentina Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 417 Argentina Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 418 Argentina Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 419 Argentina Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 420 Argentina Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 421 Argentina Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 422 Argentina Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 423 Argentina Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 424 UAE Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 425 UAE Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 426 UAE Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 427 UAE Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 428 UAE Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 429 UAE Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 430 UAE Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 431 UAE Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 432 UAE Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 433 UAE Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 434 Saudi Arabia Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 435 Saudi Arabia Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 436 Saudi Arabia Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 437 Saudi Arabia Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 438 Saudi Arabia Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 439 Saudi Arabia Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 440 Saudi Arabia Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 441 Saudi Arabia Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 442 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 443 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 444 South Africa Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 445 South Africa Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 446 South Africa Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 447 South Africa Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 448 South Africa Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 449 South Africa Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 450 South Africa Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 451 South Africa Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 452 South Africa Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 453 South Africa Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 454 Nigeria Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 455 Nigeria Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 456 Nigeria Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 457 Nigeria Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 458 Nigeria Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 459 Nigeria Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 460 Nigeria Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 461 Nigeria Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 462 Nigeria Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 463 Nigeria Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 464 Rest of LAMEA Cardiac Marker Testing Market, 2018 - 2021, USD Million
  • TABLE 465 Rest of LAMEA Cardiac Marker Testing Market, 2022 - 2028, USD Million
  • TABLE 466 Rest of LAMEA Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
  • TABLE 467 Rest of LAMEA Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
  • TABLE 468 Rest of LAMEA Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 469 Rest of LAMEA Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 470 Rest of LAMEA Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 471 Rest of LAMEA Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 472 Rest of LAMEA Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
  • TABLE 473 Rest of LAMEA Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
  • TABLE 474 Key Information - Abbott Laboratories
  • TABLE 475 Key Information - Siemens Healthineers AG
  • TABLE 476 Key information - Becton, Dickinson and Company
  • TABLE 477 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 478 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 479 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 480 Key Information - Danaher Corporation
  • TABLE 481 Key Information - DiaSorin S.p.A.
  • TABLE 482 key Information - PerkinElmer, Inc.
  • TABLE 483 Key information - BioMerieux S.A.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Global Cardiac Marker Testing Market Share by Disease, 2021
  • FIG 5 Global Cardiac Marker Testing Market Share by Disease, 2028
  • FIG 6 Global Cardiac Marker Testing Market by Disease, 2018 - 2028, USD Million
  • FIG 7 Global Cardiac Marker Testing Market Share by End User, 2021
  • FIG 8 Global Cardiac Marker Testing Market Share by End User, 2028
  • FIG 9 Global Cardiac Marker Testing Market by End User, 2018 - 2028, USD Million
  • FIG 10 Global Cardiac Marker Testing Market Share by Product, 2021
  • FIG 11 Global Cardiac Marker Testing Market Share by Product, 2028
  • FIG 12 Global Cardiac Marker Testing Market by Product, 2018 - 2028, USD Million
  • FIG 13 Global Cardiac Marker Testing Market Share by Biomarker Type, 2021
  • FIG 14 Global Cardiac Marker Testing Market Share by Biomarker Type, 2028
  • FIG 15 Global Cardiac Marker Testing Market by Biomarker Type, 2018 - 2028, USD Million
  • FIG 16 Global Cardiac Marker Testing Market Share by Region, 2021
  • FIG 17 Global Cardiac Marker Testing Market Share by Region, 2028
  • FIG 18 Global Cardiac Marker Testing Market by Region, 2018 - 2028, USD Million
  • FIG 19 Recent strategies and developments: Abbott Laboratories
  • FIG 20 Swot analysis: Abbott laboratories
  • FIG 21 Recent strategies and developments: Siemens Healthineers AG
  • FIG 22 Swot analysis: Siemens AG
  • FIG 23 Recent strategies and developments: Thermo Fisher Scientific, Inc.
目次

The Global Cardiac Marker Testing Market size is expected to reach $8.1 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.

Protein molecules known as cardiac biomarkers are released into the blood following heart injury or heart stress. These biomarkers may be used to identify a number of cardiovascular disorders (CVD), such as acute coronary syndrome, cardiac ischemia, congestive heart failure, and myocardial infarction (ACS). The doctor can assess a patient's risk of contracting such conditions using cardiac biomarker tests.

Chemicals known as cardiac markers are released into the blood by the stressed or wounded heart. Acute coronary syndrome (ACS) and cardiac ischemia, disorders linked with insufficient blood supply to the heart, are diagnosed with the use of measurements of these biomarkers. Tests for cardiac biomarkers can also be employed to assess a person's likelihood of developing these diseases as well as to monitor and treat someone who has myocardial ischemia and probable ACS.

The development of plaque in artery walls and arterial hardening are typically the primary causes of both ACS as well as cardiac ischemia. This may lead to an abrupt obstruction of blood flow through these coronary arteries or a significant constriction of the arteries leading to the heart.

Troponin is the currently preferred biomarker test for identifying heart injury. In other circumstances, such as skeletal muscle injury, additional cardiac biomarkers may be raised and are less specific for the heart. The diagnosis, risk assessment, and treatment of patients with suspected acute coronary syndrome (ACS), acute heart failure, pulmonary embolism, and other disease states, as well as the prognosis for patients with these disorders, all rely on cardiac signs.

COVID-19 Impact Analysis

The cardiac markers testing market is anticipated to continue to benefit from the COVID-19 pandemic's effects. This is due to an increase in COVID-19 patients who have preexisting medical conditions, including cardiovascular illnesses and other conditions. Since there are more heart attacks in these patients with pre-existing medical disorders like cardiovascular disease, Troponin levels were also thought to be significantly greater in COVID-19 patients who passed away or were in critical condition. For patients with COVID-19, this has increased the demand for cardiac biomarker testing. Thus, taking into consideration all of these variables, the market for cardiac markers testing shows significant growth throughout this pandemic and is anticipated to increase further.

Market Growth Factors

Rising Prevalence Of Cardiovascular Diseases

Numerous diseases and disorders are on the rise as people's lifestyles transform rapidly around the world. Lifestyle changes can lead to major health problems, including cardiovascular disease. An unhealthy diet, lack of physical activity, tobacco use, and excessive alcohol consumption are the primary modifiable risk factors for cardiovascular disease and stroke. Symptoms including hypertension, abnormal lipid profiles, diabetes, and obesity can all be attributed to a person's lifestyle choices.

Growth Of Healthcare Spending

One major factor increasing access to cardiac markers testing is the developing healthcare systems of various countries across the world. As a result of the increase in cancers diseases, and other disorders, governments around the world are investing more time and money into their healthcare systems. In addition, the healthcare industry is being pushed to adapt to new challenges by the ongoing pandemic, which continues to demand the attention and resources of healthcare systems around the world.

Market Restraining Factors

Technical Issues With Sample Storage & Collecting

For the purpose of carrying out research into the various stages that diseases can progress through in humans, epidemiology studies make use of cardiac biomarkers. In order to extract a significant quantity of knowledge from a small number of biological samples, this method necessitates the careful processing and long-term storage of these samples. It is imperative that these samples undergo a thorough quality check in order to ensure the appropriate conditions for storage and prevent the loss of data.

Product Outlook

Based on products, the cardiac marker testing market is segmented into reagents & kits and instruments. The instruments segment acquired a substantial revenue share in the cardiac marker testing market in 2021. To help identify the occurrence of ACS as well as cardiac ischemia and to assess their severity, cardiac biomarker tests are prescribed. A person with ACS or cardiac ischemia can be identified by rises in one or even more cardiac markers in the blood, enabling a quick and precise diagnosis and the right course of therapy.

Biomarker Type Outlook

On the basis of biomarker type, the cardiac marker testing market is fragmented into Troponin I & T, creatine kinase-MB(CK-MB), natriuretic peptide (Bnp Or Nt-Probnp), myoglobin, high-sensitivity C-reactive protein(hs-CRP), and other cardiac biomarkers. In 2021, the troponin I & T segment held the largest revenue share in the cardiac marker testing market. Due to its better sensitivity and specificity, cardiac troponin is the preferred biomarker again for the diagnosis of acute myocardial infarction. Recently, a number of high-sensitivity troponin tests have been introduced to the market.

Disease Outlook

By disease, the cardiac marker testing market is divided into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and ischemia. In 2021, the acute coronary syndrome segment registered a substantial revenue share in the cardiac marker testing market. This is due to the rapidly increasing illness burden in poor and medium-income countries relative to high-income countries.

End User Outlook

Based on end user, the cardiac marker testing market is classified into laboratory testing facilities, point of care testing facilities and academic institutions. In 2021, the laboratory testing segment generated the maximum revenue share in the cardiac marker testing market. This growth is attributable to factors such as the reform in healthcare infrastructure, the rise in healthcare spending, the rise in spending power, and initiatives for preventing heart attacks.

Regional Outlook

Region wise, the cardiac marker testing market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region led the cardiac marker testing market with the highest revenue share. Several factors contribute to this which include, substantial investment in research and development, the presence of key players and ready access to their products, and a

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. is the major forerunner in the Cardiac Marker Testing Market. Companies such as Abbott Laboratories, Thermo Fisher Scientific, Inc. and Danaher Corporation are some of the key innovators in Cardiac Marker Testing Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG (Siemens AG), PerkinElmer, Inc., BioMerieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and DiaSorin S.p.A.

Strategies deployed in Cardiac Marker Testing Market

Sep-2022: Abbott introduced Amplatzer Talisman patent foramen ovale. This launch aimed to address patients with PFO who are at risk of having a stroke. The launch would enhance the ease to use along with reducing time for doctors.

Aug-2022: Bio-Rad acquired Curiosity Diagnostics, a late-stage, pre-commercial platform company. This acquisition aimed at working closely to bring the latest generation of rapid PCR systems to market. Curiosity's PCR platform, PCR|ONE would offer a streamlined workflow as well as rapid turnaround times and is predicted to extend its reach beyond high-complexity labs into near-patient molecular diagnostics labs.

Apr-2022: PerkinElmer expanded its existing vivo imaging portfolio by introducing Vega, a kind ultrasound platform that combines hands-free, automated technology. This expansion aimed at accelerating non-invasive research & drug development studies of liver, cancer, and kidney disease, cardiology, and more.

Apr-2022: Roche expanded its existing cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP) portfolio by releasing the five additional uses of these cardiac biomarkers. The latest features would add real value for clinicians by supporting cardiac risk identification and enhancing diagnosis.

Apr-2021: Siemens Healthineers' signed an agreement with Biognosys, a leader in next-generation proteomics solutions for drug discovery and development. Under this agreement, Biognosys' expertise in unbiased biomarker discovery solutions and technologies would be combined with Siemens Healthineers' biomarker assay development, lab testing, and commercialization capabilities. The agreement aimed at accelerating diagnostic protein biomarkers discovery and assay development.

Mar-2021: Thermo Fisher Scientific collaborated with Mayo Clinic, a nonprofit American academic medical center. This collaboration focused on accelerating clinical validation & commercialization of certain next-generation sequencing (NGS), mass spectrometry, and immunology diagnostic tools. This acquisition would leverage NGS, mass spectrometry, and immunology technologies to enhance hematology, oncology, allergy, and autoimmunity diagnostics.

Feb-2021: Thermo Fisher Scientific acquired Mesa Biotech, a healthcare test, and data company. The acquisition aimed at rapidly scaling manufacturing volume, driving cost efficiencies as well as bringing much-needed diagnostics to market faster and at an expanded scale.

Sep-2020: Siemens Healthineers teamed up with Novartis Pharma AG, a global healthcare company. Under this collaboration, the companies would develop, design, and commercialize diagnostic tests for therapeutic products across Novartis' therapeutic pipeline. Through this collaboration, the company further focused on yielding innovative diagnostic solutions to address critical unmet clinical needs. The collaboration aimed at leveraging Siemens Healthineers' expertise in the development of innovative clinical diagnostic solutions.

Oct-2019: Siemens Healthineers took over Corindus Vascular Robotics, a global technology leader in robotic-assisted vascular interventions. The acquisition would open up a new field for its advanced therapies business, tapping into adjacent growth markets with great potential in the upcoming years. With this acquisition, the company aimed at transforming healthcare delivery to provide better care at a lower cost.

Sep-2019: Abbott unveiled ARCHITECT STAT; high sensitivity Troponin-I blood test. By this launch, U.S. doctors would be able to utilize this proven technology to help detect heart attacks faster with more accuracy than contemporary troponin tests.

Jul-2018: Siemens Healthineers launched two latest assays for quick acute myocardial infarction or heart attack diagnosis. The launch would support testing initiatives by using data to accurately triage patients early or rule out myocardial infarctions.

Apr-2018: BioMerieux signed an agreement to acquire Astute Medical, a company dedicated to improving the diagnosis of high-risk medical conditions and diseases. By this acquisition, BioMerieux would develop the NEPHROCHECK test, an FDA-cleared test based on the level of two biomarkers, IGFBP-7 and TIMP-2. The latest test would enable early risk assessment of AKI, a reduction in the occurrence of moderate to severe AKI following cardiac surgery.

Scope of the Study

Market Segments covered in the Report:

By Disease

  • Myocardial Infarction
  • Congestive Heart Failure
  • Atherosclerosis
  • Acute Coronary Syndrome
  • Ischemia

By End User

  • Laboratory Testing Facilities
  • Point-of-Care Testing Facilities
  • Academic Institutions

By Product

  • Reagents & Kits
  • Instruments

By Biomarker Type

  • Troponin I & T
  • Creatine kinase-MB(CK-MB)
  • Natriuretic peptide (Bnp Or Nt-Probnp)
  • Myoglobin
  • High-sensitivity C-reactive protein(hs-CRP)
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG (Siemens AG)
  • PerkinElmer, Inc.
  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • DiaSorin S.p.A.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cardiac Marker Testing Market, by Disease
    • 1.4.2 Global Cardiac Marker Testing Market, by End User
    • 1.4.3 Global Cardiac Marker Testing Market, by Product
    • 1.4.4 Global Cardiac Marker Testing Market, by Biomarker Type
    • 1.4.5 Global Cardiac Marker Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Trails & Approvals
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Cardiac Marker Testing Market by Disease

  • 4.1 Global Myocardial Infarction Market by Region
  • 4.2 Global Congestive Heart Failure Market by Region
  • 4.3 Global Atherosclerosis Market by Region
  • 4.4 Global Acute Coronary Syndrome Market by Region
  • 4.5 Global Ischemia Market by Region

Chapter 5. Global Cardiac Marker Testing Market by End User

  • 5.1 Global Laboratory Testing Facilities Market by Region
  • 5.2 Global Point-of-Care Testing Facilities Market by Region
  • 5.3 Global Academic Institutions Market by Region

Chapter 6. Global Cardiac Marker Testing Market by Product

  • 6.1 Global Reagents & Kits Market by Region
  • 6.2 Global Instruments Market by Region

Chapter 7. Global Cardiac Marker Testing Market by Biomarker Type

  • 7.1 Global Troponin I & T Market by Region
  • 7.2 Global Creatine kinase-MB(CK-MB) Market by Region
  • 7.3 Global Natriuretic peptide (Bnp Or Nt-Probnp) Market by Region
  • 7.4 Global Myoglobin Market by Region
  • 7.5 Global High-sensitivity C-reactive protein(hs-CRP) Market by Region
  • 7.6 Global Others Market by Region

Chapter 8. Global Cardiac Marker Testing Market by Region

  • 8.1 North America Cardiac Marker Testing Market
    • 8.1.1 North America Cardiac Marker Testing Market by Disease
      • 8.1.1.1 North America Myocardial Infarction Market by Country
      • 8.1.1.2 North America Congestive Heart Failure Market by Country
      • 8.1.1.3 North America Atherosclerosis Market by Country
      • 8.1.1.4 North America Acute Coronary Syndrome Market by Country
      • 8.1.1.5 North America Ischemia Market by Country
    • 8.1.2 North America Cardiac Marker Testing Market by End User
      • 8.1.2.1 North America Laboratory Testing Facilities Market by Country
      • 8.1.2.2 North America Point-of-Care Testing Facilities Market by Country
      • 8.1.2.3 North America Academic Institutions Market by Country
    • 8.1.3 North America Cardiac Marker Testing Market by Product
      • 8.1.3.1 North America Reagents & Kits Market by Country
      • 8.1.3.2 North America Instruments Market by Country
    • 8.1.4 North America Cardiac Marker Testing Market by Biomarker Type
      • 8.1.4.1 North America Troponin I & T Market by Country
      • 8.1.4.2 North America Creatine kinase-MB(CK-MB) Market by Country
      • 8.1.4.3 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
      • 8.1.4.4 North America Myoglobin Market by Country
      • 8.1.4.5 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country
      • 8.1.4.6 North America Others Market by Country
    • 8.1.5 North America Cardiac Marker Testing Market by Country
      • 8.1.5.1 US Cardiac Marker Testing Market
        • 8.1.5.1.1 US Cardiac Marker Testing Market by Disease
        • 8.1.5.1.2 US Cardiac Marker Testing Market by End User
        • 8.1.5.1.3 US Cardiac Marker Testing Market by Product
        • 8.1.5.1.4 US Cardiac Marker Testing Market by Biomarker Type
      • 8.1.5.2 Canada Cardiac Marker Testing Market
        • 8.1.5.2.1 Canada Cardiac Marker Testing Market by Disease
        • 8.1.5.2.2 Canada Cardiac Marker Testing Market by End User
        • 8.1.5.2.3 Canada Cardiac Marker Testing Market by Product
        • 8.1.5.2.4 Canada Cardiac Marker Testing Market by Biomarker Type
      • 8.1.5.3 Mexico Cardiac Marker Testing Market
        • 8.1.5.3.1 Mexico Cardiac Marker Testing Market by Disease
        • 8.1.5.3.2 Mexico Cardiac Marker Testing Market by End User
        • 8.1.5.3.3 Mexico Cardiac Marker Testing Market by Product
        • 8.1.5.3.4 Mexico Cardiac Marker Testing Market by Biomarker Type
      • 8.1.5.4 Rest of North America Cardiac Marker Testing Market
        • 8.1.5.4.1 Rest of North America Cardiac Marker Testing Market by Disease
        • 8.1.5.4.2 Rest of North America Cardiac Marker Testing Market by End User
        • 8.1.5.4.3 Rest of North America Cardiac Marker Testing Market by Product
        • 8.1.5.4.4 Rest of North America Cardiac Marker Testing Market by Biomarker Type
  • 8.2 Europe Cardiac Marker Testing Market
    • 8.2.1 Europe Cardiac Marker Testing Market by Disease
      • 8.2.1.1 Europe Myocardial Infarction Market by Country
      • 8.2.1.2 Europe Congestive Heart Failure Market by Country
      • 8.2.1.3 Europe Atherosclerosis Market by Country
      • 8.2.1.4 Europe Acute Coronary Syndrome Market by Country
      • 8.2.1.5 Europe Ischemia Market by Country
    • 8.2.2 Europe Cardiac Marker Testing Market by End User
      • 8.2.2.1 Europe Laboratory Testing Facilities Market by Country
      • 8.2.2.2 Europe Point-of-Care Testing Facilities Market by Country
      • 8.2.2.3 Europe Academic Institutions Market by Country
    • 8.2.3 Europe Cardiac Marker Testing Market by Product
      • 8.2.3.1 Europe Reagents & Kits Market by Country
      • 8.2.3.2 Europe Instruments Market by Country
    • 8.2.4 Europe Cardiac Marker Testing Market by Biomarker Type
      • 8.2.4.1 Europe Troponin I & T Market by Country
      • 8.2.4.2 Europe Creatine kinase-MB(CK-MB) Market by Country
      • 8.2.4.3 Europe Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
      • 8.2.4.4 Europe Myoglobin Market by Country
      • 8.2.4.5 Europe High-sensitivity C-reactive protein(hs-CRP) Market by Country
      • 8.2.4.6 Europe Others Market by Country
    • 8.2.5 Europe Cardiac Marker Testing Market by Country
      • 8.2.5.1 Germany Cardiac Marker Testing Market
        • 8.2.5.1.1 Germany Cardiac Marker Testing Market by Disease
        • 8.2.5.1.2 Germany Cardiac Marker Testing Market by End User
        • 8.2.5.1.3 Germany Cardiac Marker Testing Market by Product
        • 8.2.5.1.4 Germany Cardiac Marker Testing Market by Biomarker Type
      • 8.2.5.2 UK Cardiac Marker Testing Market
        • 8.2.5.2.1 UK Cardiac Marker Testing Market by Disease
        • 8.2.5.2.2 UK Cardiac Marker Testing Market by End User
        • 8.2.5.2.3 UK Cardiac Marker Testing Market by Product
        • 8.2.5.2.4 UK Cardiac Marker Testing Market by Biomarker Type
      • 8.2.5.3 France Cardiac Marker Testing Market
        • 8.2.5.3.1 France Cardiac Marker Testing Market by Disease
        • 8.2.5.3.2 France Cardiac Marker Testing Market by End User
        • 8.2.5.3.3 France Cardiac Marker Testing Market by Product
        • 8.2.5.3.4 France Cardiac Marker Testing Market by Biomarker Type
      • 8.2.5.4 Russia Cardiac Marker Testing Market
        • 8.2.5.4.1 Russia Cardiac Marker Testing Market by Disease
        • 8.2.5.4.2 Russia Cardiac Marker Testing Market by End User
        • 8.2.5.4.3 Russia Cardiac Marker Testing Market by Product
        • 8.2.5.4.4 Russia Cardiac Marker Testing Market by Biomarker Type
      • 8.2.5.5 Spain Cardiac Marker Testing Market
        • 8.2.5.5.1 Spain Cardiac Marker Testing Market by Disease
        • 8.2.5.5.2 Spain Cardiac Marker Testing Market by End User
        • 8.2.5.5.3 Spain Cardiac Marker Testing Market by Product
        • 8.2.5.5.4 Spain Cardiac Marker Testing Market by Biomarker Type
      • 8.2.5.6 Italy Cardiac Marker Testing Market
        • 8.2.5.6.1 Italy Cardiac Marker Testing Market by Disease
        • 8.2.5.6.2 Italy Cardiac Marker Testing Market by End User
        • 8.2.5.6.3 Italy Cardiac Marker Testing Market by Product
        • 8.2.5.6.4 Italy Cardiac Marker Testing Market by Biomarker Type
      • 8.2.5.7 Rest of Europe Cardiac Marker Testing Market
        • 8.2.5.7.1 Rest of Europe Cardiac Marker Testing Market by Disease
        • 8.2.5.7.2 Rest of Europe Cardiac Marker Testing Market by End User
        • 8.2.5.7.3 Rest of Europe Cardiac Marker Testing Market by Product
        • 8.2.5.7.4 Rest of Europe Cardiac Marker Testing Market by Biomarker Type
  • 8.3 Asia Pacific Cardiac Marker Testing Market
    • 8.3.1 Asia Pacific Cardiac Marker Testing Market by Disease
      • 8.3.1.1 Asia Pacific Myocardial Infarction Market by Country
      • 8.3.1.2 Asia Pacific Congestive Heart Failure Market by Country
      • 8.3.1.3 Asia Pacific Atherosclerosis Market by Country
      • 8.3.1.4 Asia Pacific Acute Coronary Syndrome Market by Country
      • 8.3.1.5 Asia Pacific Ischemia Market by Country
    • 8.3.2 Asia Pacific Cardiac Marker Testing Market by End User
      • 8.3.2.1 Asia Pacific Laboratory Testing Facilities Market by Country
      • 8.3.2.2 Asia Pacific Point-of-Care Testing Facilities Market by Country
      • 8.3.2.3 Asia Pacific Academic Institutions Market by Country
    • 8.3.3 Asia Pacific Cardiac Marker Testing Market by Product
      • 8.3.3.1 Asia Pacific Reagents & Kits Market by Country
      • 8.3.3.2 Asia Pacific Instruments Market by Country
    • 8.3.4 Asia Pacific Cardiac Marker Testing Market by Biomarker Type
      • 8.3.4.1 Asia Pacific Troponin I & T Market by Country
      • 8.3.4.2 Asia Pacific Creatine kinase-MB(CK-MB) Market by Country
      • 8.3.4.3 Asia Pacific Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
      • 8.3.4.4 Asia Pacific Myoglobin Market by Country
      • 8.3.4.5 Asia Pacific High-sensitivity C-reactive protein(hs-CRP) Market by Country
      • 8.3.4.6 Asia Pacific Others Market by Country
    • 8.3.5 Asia Pacific Cardiac Marker Testing Market by Country
      • 8.3.5.1 China Cardiac Marker Testing Market
        • 8.3.5.1.1 China Cardiac Marker Testing Market by Disease
        • 8.3.5.1.2 China Cardiac Marker Testing Market by End User
        • 8.3.5.1.3 China Cardiac Marker Testing Market by Product
        • 8.3.5.1.4 China Cardiac Marker Testing Market by Biomarker Type
      • 8.3.5.2 Japan Cardiac Marker Testing Market
        • 8.3.5.2.1 Japan Cardiac Marker Testing Market by Disease
        • 8.3.5.2.2 Japan Cardiac Marker Testing Market by End User
        • 8.3.5.2.3 Japan Cardiac Marker Testing Market by Product
        • 8.3.5.2.4 Japan Cardiac Marker Testing Market by Biomarker Type
      • 8.3.5.3 India Cardiac Marker Testing Market
        • 8.3.5.3.1 India Cardiac Marker Testing Market by Disease
        • 8.3.5.3.2 India Cardiac Marker Testing Market by End User
        • 8.3.5.3.3 India Cardiac Marker Testing Market by Product
        • 8.3.5.3.4 India Cardiac Marker Testing Market by Biomarker Type
      • 8.3.5.4 South Korea Cardiac Marker Testing Market
        • 8.3.5.4.1 South Korea Cardiac Marker Testing Market by Disease
        • 8.3.5.4.2 South Korea Cardiac Marker Testing Market by End User
        • 8.3.5.4.3 South Korea Cardiac Marker Testing Market by Product
        • 8.3.5.4.4 South Korea Cardiac Marker Testing Market by Biomarker Type
      • 8.3.5.5 Singapore Cardiac Marker Testing Market
        • 8.3.5.5.1 Singapore Cardiac Marker Testing Market by Disease
        • 8.3.5.5.2 Singapore Cardiac Marker Testing Market by End User
        • 8.3.5.5.3 Singapore Cardiac Marker Testing Market by Product
        • 8.3.5.5.4 Singapore Cardiac Marker Testing Market by Biomarker Type
      • 8.3.5.6 Malaysia Cardiac Marker Testing Market
        • 8.3.5.6.1 Malaysia Cardiac Marker Testing Market by Disease
        • 8.3.5.6.2 Malaysia Cardiac Marker Testing Market by End User
        • 8.3.5.6.3 Malaysia Cardiac Marker Testing Market by Product
        • 8.3.5.6.4 Malaysia Cardiac Marker Testing Market by Biomarker Type
      • 8.3.5.7 Rest of Asia Pacific Cardiac Marker Testing Market
        • 8.3.5.7.1 Rest of Asia Pacific Cardiac Marker Testing Market by Disease
        • 8.3.5.7.2 Rest of Asia Pacific Cardiac Marker Testing Market by End User
        • 8.3.5.7.3 Rest of Asia Pacific Cardiac Marker Testing Market by Product
        • 8.3.5.7.4 Rest of Asia Pacific Cardiac Marker Testing Market by Biomarker Type
  • 8.4 LAMEA Cardiac Marker Testing Market
    • 8.4.1 LAMEA Cardiac Marker Testing Market by Disease
      • 8.4.1.1 LAMEA Myocardial Infarction Market by Country
      • 8.4.1.2 LAMEA Congestive Heart Failure Market by Country
      • 8.4.1.3 LAMEA Atherosclerosis Market by Country
      • 8.4.1.4 LAMEA Acute Coronary Syndrome Market by Country
      • 8.4.1.5 LAMEA Ischemia Market by Country
    • 8.4.2 LAMEA Cardiac Marker Testing Market by End User
      • 8.4.2.1 LAMEA Laboratory Testing Facilities Market by Country
      • 8.4.2.2 LAMEA Point-of-Care Testing Facilities Market by Country
      • 8.4.2.3 LAMEA Academic Institutions Market by Country
    • 8.4.3 LAMEA Cardiac Marker Testing Market by Product
      • 8.4.3.1 LAMEA Reagents & Kits Market by Country
      • 8.4.3.2 LAMEA Instruments Market by Country
    • 8.4.4 LAMEA Cardiac Marker Testing Market by Biomarker Type
      • 8.4.4.1 LAMEA Troponin I & T Market by Country
      • 8.4.4.2 LAMEA Creatine kinase-MB(CK-MB) Market by Country
      • 8.4.4.3 LAMEA Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
      • 8.4.4.4 LAMEA Myoglobin Market by Country
      • 8.4.4.5 LAMEA High-sensitivity C-reactive protein(hs-CRP) Market by Country
      • 8.4.4.6 LAMEA Others Market by Country
    • 8.4.5 LAMEA Cardiac Marker Testing Market by Country
      • 8.4.5.1 Brazil Cardiac Marker Testing Market
        • 8.4.5.1.1 Brazil Cardiac Marker Testing Market by Disease
        • 8.4.5.1.2 Brazil Cardiac Marker Testing Market by End User
        • 8.4.5.1.3 Brazil Cardiac Marker Testing Market by Product
        • 8.4.5.1.4 Brazil Cardiac Marker Testing Market by Biomarker Type
      • 8.4.5.2 Argentina Cardiac Marker Testing Market
        • 8.4.5.2.1 Argentina Cardiac Marker Testing Market by Disease
        • 8.4.5.2.2 Argentina Cardiac Marker Testing Market by End User
        • 8.4.5.2.3 Argentina Cardiac Marker Testing Market by Product
        • 8.4.5.2.4 Argentina Cardiac Marker Testing Market by Biomarker Type
      • 8.4.5.3 UAE Cardiac Marker Testing Market
        • 8.4.5.3.1 UAE Cardiac Marker Testing Market by Disease
        • 8.4.5.3.2 UAE Cardiac Marker Testing Market by End User
        • 8.4.5.3.3 UAE Cardiac Marker Testing Market by Product
        • 8.4.5.3.4 UAE Cardiac Marker Testing Market by Biomarker Type
      • 8.4.5.4 Saudi Arabia Cardiac Marker Testing Market
        • 8.4.5.4.1 Saudi Arabia Cardiac Marker Testing Market by Disease
        • 8.4.5.4.2 Saudi Arabia Cardiac Marker Testing Market by End User
        • 8.4.5.4.3 Saudi Arabia Cardiac Marker Testing Market by Product
        • 8.4.5.4.4 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type
      • 8.4.5.5 South Africa Cardiac Marker Testing Market
        • 8.4.5.5.1 South Africa Cardiac Marker Testing Market by Disease
        • 8.4.5.5.2 South Africa Cardiac Marker Testing Market by End User
        • 8.4.5.5.3 South Africa Cardiac Marker Testing Market by Product
        • 8.4.5.5.4 South Africa Cardiac Marker Testing Market by Biomarker Type
      • 8.4.5.6 Nigeria Cardiac Marker Testing Market
        • 8.4.5.6.1 Nigeria Cardiac Marker Testing Market by Disease
        • 8.4.5.6.2 Nigeria Cardiac Marker Testing Market by End User
        • 8.4.5.6.3 Nigeria Cardiac Marker Testing Market by Product
        • 8.4.5.6.4 Nigeria Cardiac Marker Testing Market by Biomarker Type
      • 8.4.5.7 Rest of LAMEA Cardiac Marker Testing Market
        • 8.4.5.7.1 Rest of LAMEA Cardiac Marker Testing Market by Disease
        • 8.4.5.7.2 Rest of LAMEA Cardiac Marker Testing Market by End User
        • 8.4.5.7.3 Rest of LAMEA Cardiac Marker Testing Market by Product
        • 8.4.5.7.4 Rest of LAMEA Cardiac Marker Testing Market by Biomarker Type

Chapter 9. Company Profiles

  • 9.1 Abbott Laboratories
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Product Launches and Product Expansions:
      • 9.1.5.2 Approvals and Trials:
    • 9.1.6 SWOT Analysis
  • 9.2 Siemens Healthineers AG (Siemens AG)
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
      • 9.2.5.3 Acquisition and Mergers:
    • 9.2.6 SWOT Analysis
  • 9.3 Becton, Dickinson and Company
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
  • 9.4 F. Hoffmann-La Roche Ltd.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Product Launches and Product Expansions:
  • 9.5 Thermo Fisher Scientific, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
      • 9.5.5.2 Acquisition and Mergers:
  • 9.6 Bio-Rad laboratories, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental and Regional Analysis
    • 9.6.4 Research & Development Expenses
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Acquisition and Mergers:
  • 9.7 Danaher Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expense
  • 9.8 DiaSorin S.p.A.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Research & Development Expenses
  • 9.9 PerkinElmer, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Product Launches and Product Expansions:
  • 9.10. BioMerieux S.A.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 Recent strategies and developments:
      • 9.10.5.1 Partnerships, Collaborations, and Agreements: